Follow
Blancafort Pilar
Blancafort Pilar
The Harry Perkins Institute of Medical Research, University of Western Australia
Verified email at uwa.edu.au
Title
Cited by
Cited by
Year
Breastmilk is a novel source of stem cells with multilineage differentiation potential
F Hassiotou, A Beltran, E Chetwynd, AM Stuebe, AJ Twigger, P Metzger, ...
Stem cells 30 (10), 2164-2174, 2012
3422012
Epigenetic reprogramming of cancer cells via targeted DNA methylation
AG Rivenbark, S Stolzenburg, AS Beltran, X Yuan, MG Rots, BD Strahl, ...
Epigenetics 7 (4), 350-360, 2012
3372012
Systemic delivery of modified mRNA encoding herpes simplex virus 1 thymidine kinase for targeted cancer gene therapy
Y Wang, H Su, Y Yang, Y Hu, L Zhang, P Blancafort, L Huang
Molecular Therapy 21 (2), 358-367, 2013
3212013
Development of zinc finger domains for recognition of the 5′-CNN-3′ family DNA sequences and their use in the construction of artificial transcription factors
B Dreier, RP Fuller, DJ Segal, CV Lund, P Blancafort, A Huber, B Koksch, ...
Journal of Biological Chemistry 280 (42), 35588-35597, 2005
2682005
Evaluation of a modular strategy for the construction of novel polydactyl zinc finger DNA-binding proteins
DJ Segal, RR Beerli, P Blancafort, B Dreier, K Effertz, A Huber, B Koksch, ...
Biochemistry 42 (7), 2137-2148, 2003
2542003
Designing transcription factor architectures for drug discovery
P Blancafort, DJ Segal, CF Barbas
Molecular pharmacology 66 (6), 1361-1371, 2004
2252004
Targeted silencing of the oncogenic transcription factor SOX2 in breast cancer
S Stolzenburg, MG Rots, AS Beltran, AG Rivenbark, X Yuan, H Qian, ...
Nucleic acids research 40 (14), 6725-6740, 2012
1922012
Scanning the human genome with combinatorial transcription factor libraries
P Blancafort, L Magnenat, CF Barbas III
Nature biotechnology 21 (3), 269-274, 2003
1652003
Honeybee venom and melittin suppress growth factor receptor activation in HER2-enriched and triple-negative breast cancer
C Duffy, A Sorolla, E Wang, E Golden, E Woodward, K Davern, D Ho, ...
NPJ precision oncology 4 (1), 24, 2020
1312020
Synthetically controlling dendrimer flexibility improves delivery of large plasmid DNA
JA Kretzmann, D Ho, CW Evans, JHC Plani-Lam, B Garcia-Bloj, ...
Chemical science 8 (4), 2923-2930, 2017
1312017
Hallmarks of cancer: The CRISPR generation
C Moses, B Garcia-Bloj, AR Harvey, P Blancafort
European Journal of Cancer 93, 10-18, 2018
1292018
Zinc fingers, TALEs, and CRISPR systems: a comparison of tools for epigenome editing
CB Waryah, C Moses, M Arooj, P Blancafort
Epigenome editing: methods and protocols, 19-63, 2018
1162018
Re-activation of a dormant tumor suppressor gene maspin by designed transcription factors
A Beltran, S Parikh, Y Liu, BD Cuevas, GL Johnson, BW Futscher, ...
Oncogene 26 (19), 2791-2798, 2007
1162007
Generation of tumor-initiating cells by exogenous delivery of OCT4transcription factor
AS Beltran, AG Rivenbark, BT Richardson, X Yuan, H Quian, JP Hunt, ...
Breast cancer research 13, 1-21, 2011
1142011
Activating PTEN tumor suppressor expression with the CRISPR/dCas9 system
C Moses, F Nugent, CB Waryah, B Garcia-Bloj, AR Harvey, P Blancafort
Molecular Therapy-Nucleic Acids 14, 287-300, 2019
1102019
Gene expression in breastmilk cells is associated with maternal and infant characteristics
AJ Twigger, AR Hepworth, C Tat Lai, E Chetwynd, AM Stuebe, ...
Scientific reports 5 (1), 12933, 2015
1052015
Stable oncogenic silencing in vivo by programmable and targeted de novo DNA methylation in breast cancer
S Stolzenburg, AS Beltran, T Swift-Scanlan, AG Rivenbark, R Rashwan, ...
Oncogene 34 (43), 5427-5435, 2015
1042015
Precision medicine by designer interference peptides: applications in oncology and molecular therapeutics
A Sorolla, E Wang, E Golden, C Duffy, ST Henriques, AD Redfern, ...
Oncogene 39 (6), 1167-1184, 2020
922020
Cisplatin induces differentiation of breast cancer cells
P Prabhakaran, F Hassiotou, P Blancafort, L Filgueira
Frontiers in oncology 3, 134, 2013
922013
Novel role of Engrailed 1 as a prosurvival transcription factor in basal-like breast cancer and engineering of interference peptides block its oncogenic function
AS Beltran, LM Graves, P Blancafort
Oncogene 33 (39), 4767-4777, 2014
912014
The system can't perform the operation now. Try again later.
Articles 1–20